7 results
Proton Pump Inhibitor (PPI) - Adverse Effects and Prescribing Tips

#Management #Pharmacology #PPI #Adverse #SideEffects #Prescribing #ProtonPumpInhibitor
Inhibitor (PPI) - Adverse ... Prescribing Tips #Management ... #Pharmacology # ... PPI #Adverse #SideEffects
Amiodarone Toxicity and Monitoring

Tremor Ataxia 
Ocular neuritis 
Corneal Microdeposits 
Bradycardia 
Pulmonary fibrosis 
Hepatotoxicity 
Blue-gray skin
Toxicity #Monitoring #SideEffects ... #Adverse #Diagnosis ... #Management #Pharmacology
Sedative-Hypnotic Visual Decision Aid

What would happen if 100 people over 60 years of age take sleeping
#Management #Sedatives ... #DecisionAid #Pharmacology ... #Benefits #SideEffects ... #Adverse #Geriatrics
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... for significant adverse ... Tuberculosis #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... After lesions begin ... HerpesSimplex #HSV #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... Therapy) • To begin ... #Cryptococcus #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... medications, ability to adhere ... Cytomegalovirus #CMV #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology